Literature DB >> 24167693

Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review.

Kyoko Higashi1, Goran Medic, Kavi J Littlewood, Teresa Diez, Ola Granström, Marc De Hert.   

Abstract

BACKGROUND: Nonadherence to medication is a recognized problem and may be the most challenging aspect of treatment.
METHODS: We performed a systematic review of factors that influence adherence and the consequences of nonadherence to the patient, healthcare system and society, in patients with schizophrenia. Particular attention was given to the effect of nonadherence on hospitalization rates, as a key driver of increased costs of care. A qualitative systematic literature review was conducted using a broad search strategy using disease and adherence terms. Due to the large number of abstracts identified, article selection was based on studies with larger sample sizes published after 2001. Thirty-seven full papers were included: 15 studies on drivers and 22 on consequences, of which 12 assessed the link between nonadherence and hospitalization.
RESULTS: Key drivers of nonadherence included lack of insight, medication beliefs and substance abuse. Key consequences of nonadherence included greater risk of relapse, hospitalization and suicide. Factors positively related to adherence were a good therapeutic relationship with physician and perception of benefits of medication. The most frequently reported driver and consequence were lack of insight and greater risk of hospitalization respectively.
CONCLUSIONS: Improving adherence in schizophrenia may have a considerable positive impact on patients and society. This can be achieved by focusing on the identified multitude of factors driving nonadherence.

Entities:  

Keywords:  adherence; antipsychotics; nonadherence; schizophrenia; systematic review

Year:  2013        PMID: 24167693      PMCID: PMC3805432          DOI: 10.1177/2045125312474019

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  43 in total

1.  Partial compliance with antipsychotics increases mental health hospitalizations in schizophrenic patients: analysis of a national managed care database.

Authors:  Chris M Kozma; Peter J Weiden
Journal:  Am Health Drug Benefits       Date:  2009-01

2.  A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia.

Authors:  Haya Ascher-Svanum; Baojin Zhu; Douglas Faries; Jonathan P Lacro; Christian R Dolder
Journal:  J Clin Psychiatry       Date:  2006-07       Impact factor: 4.384

Review 3.  Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.

Authors:  Stefan Leucht; Stephan Heres
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

4.  Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia.

Authors:  Mark Olfson; Steven C Marcus; Joshua Wilk; Joyce C West
Journal:  Psychiatr Serv       Date:  2006-02       Impact factor: 3.084

Review 5.  Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.

Authors:  Jaromir Svestka; Istvan Bitter
Journal:  Neuro Endocrinol Lett       Date:  2007-02       Impact factor: 0.765

6.  Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes.

Authors:  Stefan Weinmann; Birgit Janssen; Wolfgang Gaebel
Journal:  J Clin Psychiatry       Date:  2004-08       Impact factor: 4.384

7.  Non-adherence to antipsychotic medication regimens: associations with resource use and costs.

Authors:  Martin Knapp; Derek King; Klaus Pugner; Pablo Lapuerta
Journal:  Br J Psychiatry       Date:  2004-06       Impact factor: 9.319

8.  Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.

Authors:  Terence V McCann; Eileen Clark; Sai Lu
Journal:  J Adv Nurs       Date:  2009-03       Impact factor: 3.187

9.  Drug maintenance treatment compliance and its correlation with the clinical picture and course of schizophrenia.

Authors:  Małgorzata Rzewuska
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-05       Impact factor: 5.067

10.  Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.

Authors:  Marcia Valenstein; Laurel A Copeland; Frederic C Blow; John F McCarthy; John E Zeber; Leah Gillon; C Raymond Bingham; Thomas Stavenger
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

View more
  113 in total

Review 1.  The Pharmacokinetics of Second-Generation Long-Acting Injectable Antipsychotics: Limitations of Monograph Values.

Authors:  Lik Hang N Lee; Charles Choi; Abby C Collier; Alasdair M Barr; William G Honer; Ric M Procyshyn
Journal:  CNS Drugs       Date:  2015-12       Impact factor: 5.749

2.  Does the Psychiatrist's Use of Subjective Well-Being Measurement in People with Schizophrenia Provide a Better Alignment with the Patient's Well-Being Perception than Clinical Judgement Alone?

Authors:  Warut Aunjitsakul; Teerapat Teetharatkul; Arnont Vitayanont; Tippawan Liabsuetrakul
Journal:  Adm Policy Ment Health       Date:  2021-03-17

3.  Does Non-Adherence Increase Treatment Costs in Schizophrenia?

Authors:  Mark Pennington; Paul McCrone
Journal:  Pharmacoeconomics       Date:  2018-08       Impact factor: 4.981

4.  Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.

Authors:  Douglas M Ruderfer; Alexander W Charney; Ben Readhead; Brian A Kidd; Anna K Kähler; Paul J Kenny; Michael J Keiser; Jennifer L Moran; Christina M Hultman; Stuart A Scott; Patrick F Sullivan; Shaun M Purcell; Joel T Dudley; Pamela Sklar
Journal:  Lancet Psychiatry       Date:  2016-02-23       Impact factor: 27.083

Review 5.  Aripiprazole Lauroxil: A Review in Schizophrenia.

Authors:  James E Frampton
Journal:  Drugs       Date:  2017-12       Impact factor: 9.546

6.  Time-lagged predictors of daily medication nonadherence beliefs during the month post-hospital discharge in patients with psychotic-spectrum disorders.

Authors:  Brandon A Gaudiano; Stacy Ellenberg; Lawrence H Price; Ethan Moitra
Journal:  Psychiatry Res       Date:  2018-09-21       Impact factor: 3.222

7.  Measuring adherence to antipsychotic medications for schizophrenia: Concordance and validity among a community sample in rural China.

Authors:  Dong Roman Xu; Wenjie Gong; Steve Gloyd; Eric D Caine; Jane Simoni; James P Hughes; Shuiyuan Xiao; Wenjun He; Bofeng Dai; Meijuan Lin; Juan Nie; Hua He
Journal:  Schizophr Res       Date:  2018-05-26       Impact factor: 4.939

8.  Characteristics of patients with mental illness and persistent high-cost status: a population-based analysis.

Authors:  Claire de Oliveira; Joyce Mason; Paul Kurdyak
Journal:  CMAJ       Date:  2020-12-14       Impact factor: 8.262

Review 9.  Medication nonadherence in bipolar disorder: a narrative review.

Authors:  Ibrahim Jawad; Stuart Watson; Peter M Haddad; Peter S Talbot; R Hamish McAllister-Williams
Journal:  Ther Adv Psychopharmacol       Date:  2018-10-16

Review 10.  Cariprazine: A Review in Schizophrenia.

Authors:  Karly P Garnock-Jones
Journal:  CNS Drugs       Date:  2017-06       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.